In this episode, our host is joined by UK-based dermatologist Dr Clive Grattan to address some of the most important unanswered questions in the field of chronic spontaneous urticaria.

LINK: www.medthority.com/csu-learning-zone/podcast-series/

Join Drs Martin Metz and Ana Maria Giménez-Arnau as they discuss the latest data on new treatments in development for chronic spontaneous urticaria.

The goal of this activity is to educate on the latest therapeutic developments for the management of patients with chronic spontaneous urticaria (CSU)

https://www.medscape.org/viewarticle/953107?src=acdmpart_ucare_953107

Martin Metz, MD; Ana Maria...

We are very pleased to announce that this year’s UCARE Conference will be held on December 9th-11th, 2021 in Hiroshima, Japan.

Dear members of the UCARE and ACARE networks,

we regret to inform you about the passing of one of our esteemed members:

Professor Marek L. Kowalski (1952-2021),

In this very special episode, our host meets Cassandra, a patient who has been affected by CSU for many years. Listen now for unmissable insights into the patient experience and to find out more about what you do to better support your own patients in the future. 

LINK: https://www.medthority.com/csu-learning-zone/podcast-series/

Did you know that not all patients with CSU develop wheals? In this episode, Professor Connie Katelaris explains the unique challenges physicians face when diagnosing and managing CSU patients who have pure angioedema without wheals, and offers advice on how to spot pseudoangioedema.

LINK: https://www.medthority.com/csu-learning-zone/podcast-series/

Join this expert discussion on key challenges in management of chronic spontaneous urticaria in clinical practice.

For those just starting out on their UCARE journey, the extensive list of criteria can seem daunting. In this episode, our host is joined by Professor Kanokvalai Kulthanan, who offers her advice on tackling the application process.

LINK: https://www.medthority.com/csu-learning-zone/podcast-series/

Join this expert discussion on the role of IgE in the pathogenesis of CSU and therapies in development.